期刊
WORLD JOURNAL OF GASTROENTEROLOGY
卷 15, 期 17, 页码 2074-2077出版社
W J G PRESS
DOI: 10.3748/wjg.15.2074
关键词
Hepatocyte transplantation; Metabolic diseases; Chronic liver disease; Liver failure; Stem cells
The shortage of organ donors is a problem worldwide, with approximately 15% of adult patients with life-threatening liver diseases dying while on the waiting list. The use of cell transplantation for liver disease is an attempt to correct metabolic defects, or to support liver function as a bridge to liver transplantation and, as such, has raised a number of expectations. Most of the available studies briefly reported here focus on adult hepatocyte transplantation (HT), and the results are neither reproducible nor comparable, because the means of infusion, amount of injected cells and clinical variability differ among the studies. To better understand the specific role of HT in the management of end-stage liver disease, it is important that controlled studies, designed on the principles of evidence-based medicine, be done in order to guarantee the reproducibility of results. (C) 2009 The WJG Press and Baishicleng. All rights reserved
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据